Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease

Translational Psychiatry

Volumn 2, Issue , 2012, Pages

  Du, X ^a   Leang, L ^a   Mustafa, T ^b   Renoir, T ^a   Pang, T Y ^a   Hannan, A J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

acute stress; adrenal gland; environmental enrichment; glucocorticoid receptor; HPA axis; Huntington's disease

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CYCLIC AMP RESPONSIVE ELEMENT MODULATOR; GLUCOCORTICOID RECEPTOR; DEXAMETHASONE;

ADRENAL CORTEX CELL; ADRENAL FUNCTION; ADRENAL HYPERPLASIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CELL STIMULATION; CELLULAR STRESS RESPONSE; CENTRAL NERVOUS SYSTEM; COGNITION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; ENVIRONMENTAL ENRICHMENT; EXERCISE TEST; FEMALE; FORCED SWIMMING TEST; GENE EXPRESSION; GENOTYPE; HIPPOCAMPUS; HORMONE RELEASE; HUNTINGTON DISEASE LIKE SYNDROME; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; UPREGULATION; ZONA FASCICULATA; ADRENAL GLAND; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; DISEASE MODEL; ENVIRONMENT; GENE EXPRESSION PROFILING; GENETICS; HUNTINGTON CHOREA; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METHODOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TRANSGENIC MOUSE;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ANALYSIS OF VARIANCE; ANIMALS; CORTICOSTERONE; DEXAMETHASONE; DISEASE MODELS, ANIMAL; ENVIRONMENT; FEMALE; GENE EXPRESSION PROFILING; HUNTINGTON DISEASE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE; MICE, TRANSGENIC; PITUITARY-ADRENAL SYSTEM; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, GLUCOCORTICOID; SEX FACTORS; STRESS, PHYSIOLOGICAL;

EID: 84866128240     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2012.58     Document Type: Article

References (47)

1. Wasserman D, Wasserman J, Sokolowski M. Genetics of HPA-axis, depression and suicidality. Eur Psychiatry 2010; 25: 278-280.
2. Petersen A, Gil J, Maat-Schieman ML, Björkqvist M, Tanila H, Araujo IM et al. Orexin loss in Huntington's disease. Hum Mol Genet 2005; 14: 39-47.
3. Petersen A, Bjorkqvist M. Hypothalamic-endocrine aspects in Huntington's disease. Eur J Neurosci 2006; 24: 961-967. (Pubitemid 44268127)
4. Sathasivam K, Hobbs C, Turmaine M, Mangiarini L, Mahal A, Bertaux F et al. Formation of polyglutamine inclusions in non-CNS tissue. Hum Mol Genet 1999; 8: 813-822. (Pubitemid 29189048)
5. Aziz NA, Pijl H, Frölich M, van der Graaf AW, Roelfsema F, Roos RA. Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease. J Clin Endocrinol Metab 2009; 94: 1223-1228.
6. van Duijn E, Selis MA, Giltay EJ, Zitman FG, Roos RA, van Pelt H et al. Hypothalamicpituitary- adrenal axis functioning in Huntington's disease mutation carriers compared with mutation-negative first-degree controls. Brain Res Bull 2010; 83: 232-237.
7. Heuser IJ, Chase TN, Mouradian MM. The limbic-hypothalamic-pituitary- adrenal axis in Huntington's disease. Biol Psychiatry 1991; 30: 943-952.
8. Bjorkqvist M, Petersén A, Bacos K, Isaacs J, Norlén P, Gil J et al. Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease. Hum Mol Genet 2006; 15: 1713-1721. (Pubitemid 43904837)
9. Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments. Trends Neurosci 2008; 31: 464-468.
10. Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med 2011; 73: 114-126.
11. Pang TY, Du X, Zajac MS, Howard ML, Hannan AJ. Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease. Hum Mol Genet 2009; 18: 753-766.
12. Groenink L, Dirks A, Verdouw PM, Schipholt M, Veening JG, van der Gugten J et al. HPA axis dysregulation in mice overexpressing corticotropin releasing hormone. Biol Psychiatry 2002; 51: 875-881. (Pubitemid 34521935)
13. Jiang X, Wang J, Luo T, Li Q. Impaired hypothalamic-pituitary-adrenal axis and its feedback regulation in serotonin transporter knockout mice. Psychoneuroendocrinology 2009; 34: 317-331.
14. Touma C, Palme R, Sachser N. Analyzing corticosterone metabolites in fecal samples of mice: a noninvasive technique to monitor stress hormones. Horm Behav 2004; 45: 10-22. (Pubitemid 38083330)
15. Chu Y,Wu BM, McCabe ER, Dunn JC. Serum-free cultures of murine adrenal cortical cells. J Pediatr Surg 2006; 41: 2008-2012. (Pubitemid 44854967)
16. Akinci MK, Johnston GA. Sex differences in the effects of acute swim stress on binding to GABAA receptors in mouse brain. J Neurochem 1993; 60: 2212-2216. (Pubitemid 23148794)
17. Furay AR, Bruestle AE, Herman JP. The role of the forebrain glucocorticoid receptor in acute and chronic stress. Endocrinology 2008; 149: 5482-5490.
18. Andrews MH, Wood SA, Windle RJ, Lightman SL, Ingram CD. Acute glucocorticoid administration rapidly suppresses basal and stress-induced hypothalamo-pituitary-adrenal axis activity. Endocrinology 2012; 153: 200-211.
19. Caroll BJ, Curtis GC, Mendels J. Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. Arch Gen Psychiatry 1976; 33: 1039-1044.
20. Kalin NH, Weiler SJ, Shelton SE. Plasma ACTH and cortisol concentrations before and after dexamethasone. Psychiatry Res 1982; 7: 87-92. (Pubitemid 13249254)
21. Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Parker Jr CR, Weissenburger JE et al. The dexamethasone suppression test in patients with mood disorders. J Clin Psychiatry 1996; 57: 470-484. (Pubitemid 26362312)
22. Handwerger K. Differential patterns of HPA activity and reactivity in adult posttraumatic stress disorder and major depressive disorder. Harv Rev Psychiatry 2009; 17: 184-205.
23. Nithianantharajah J, Hannan AJ. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neurosci 2006; 7: 697-709. (Pubitemid 44267494)
24. Cao L, Choi EY, Liu X, Martin A, Wang C, Xu X et al. White to brown fat phenotypic switch induced by genetic and environmental activation of a hypothalamic-adipocyte axis. Cell Metab 2011; 14: 324-338.
25. Chida D, Sato T, Sato Y, Kubo M, Yoda T, Suzuki H et al. Characterization of mice deficient in melanocortin 2 receptor on a B6/Balbc mix background. Mol Cell Endocrinol 2009; 300: 32-36.
26. Molina CA, Foulkes NS, Lalli E, Sassone-Corsi P. Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell 1993; 75: 875-886. (Pubitemid 24014545)
27. Lalli E, Sassone-Corsi P. Signal transduction and gene regulation: the nuclear response to cAMP. J Biol Chem 1994; 269: 17359-17362. (Pubitemid 24218002)
28. Spiga F, Liu Y, Aguilera G, Lightman SL. Temporal effect of adrenocorticotrophic hormone on adrenal glucocorticoid steroidogenesis: involvement of the transducer of regulated cyclic AMP-response element-binding protein activity. J Neuroendocrinol 2011; 23: 136-142.
29. Gummow BM, Scheys JO, Cancelli VR, Hammer GD. Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the Dax-1 promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex. Mol Endocrinol 2006; 20: 2711-2723. (Pubitemid 44833531)
30. Cole TJ, Myles K, Purton JF, Brereton PS, Solomon NM, Godfrey DI et al. GRKO mice express an aberrant dexamethasone-binding glucocorticoid receptor, but are profoundly glucocorticoid resistant. Mol Cell Endocrinol 2001; 173: 193-202. (Pubitemid 32149641)
31. Webster MJ, Knable MB, O'Grady J, Orthmann J, Weickert CS. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry 2002; 7: 985-994, 924.
32. Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, Torrey EF, Stanley Neuropathology Consortium. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 2004; 9: 609-620, 544. (Pubitemid 38850430)
33. Matsubara T, Funato H, Kobayashi A, Nobumoto M, Watanabe Y. Reduced glucocorticoid receptor alpha expression in mood disorder patients and first-degree relatives. Biol Psychiatry 2006; 59: 689-695.
34. Ridder S, Chourbaji S, Hellweg R, Urani A, Zacher C, Schmid W et al. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J Neurosci 2005; 25: 6243-6250. (Pubitemid 40923491)
35. Molteni R, Calabrese F, Chourbaji S, Brandwein C, Racagni G, Gass P et al. Depressionprone mice with reduced glucocorticoid receptor expression display an altered stressdependent regulation of brain-derived neurotrophic factor and activity-regulated cytoskeletonassociated protein. J Psychopharmacol 2010; 24: 595-603.
36. Sarai M, Taniguchi N, Kagomoto T, Kameda H, Uema T, Hishikawa Y. Major depressive episode and low dose dexamethasone suppression test. Folia Psychiatr Neurol Jpn 1982; 36: 109-114. (Pubitemid 13235323)
37. Markianos M, Panas M, Kalfakis N, Vassilopoulos D. Plasma testosterone in male patients with Huntington's disease: relations to severity of illness and dementia. Ann Neurol 2005; 57: 520-525. (Pubitemid 40471161)
38. Markianos M, Panas M, Kalfakis N, Vassilopoulos D. Plasma testosterone, dehydroepiandrosterone sulfate, and cortisol in female patients with Huntington's disease. Neuro Endocrinol Lett 2007; 28: 199-203. (Pubitemid 46739073)
39. Van Raamsdonk JM, Murphy Z, Selva DM, Hamidizadeh R, Pearson J, Petersén A et al. Testicular degeneration in Huntington disease. Neurobiol Dis 2007; 26: 512-520. (Pubitemid 46756321)
40. Hannan AJ, Ransome MI. Deficits in spermatogenesis but not neurogenesis are alleviated by chronic testosterone therapy in R6/1 Huntington's disease mice. J Neuroendocrinol 2012; 24: 341-356.
41. Papalexi E, Persson A, Björkqvist M, Petersén A, Woodman B, Bates GP et al. Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease. Eur J Neurosci 2005; 22: 1541-1546. (Pubitemid 41442425)
42. Markianos M, Panas M, Kalfakis N, Hatzimanolis J, Vassilopoulos D. Neuroendocrine evidence of normal hypothalamus-pituitary dopaminergic function in Huntington's disease. Neuro Endocrinol Lett 2010; 31: 359-362.
43. Markianos M, Panas M, Kalfakis N, Vassilopoulos D. Plasma homovanillic acid and prolactin in Huntington's disease. Neurochem Res 2009; 34: 917-922.
44. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87: 493-506. (Pubitemid 26374323)
45. Moffitt H, McPhail GD, Woodman B, Hobbs C, Bates GP. Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease. PLoS One 2009; 4: e8025.
46. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004; 7: 847-854. (Pubitemid 38989508)
47. Liu D, Diorio J, Tannenbaum B, Caldji C, Francis D, Freedman A et al. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary- adrenal responses to stress. Science 1997; 277: 1659-1662. (Pubitemid 27446227)